GTC BIOTHERAPEUTICS Trademark

Trademark Overview


On Monday, March 25, 2002, a trademark application was filed for GTC BIOTHERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the GTC BIOTHERAPEUTICS trademark a serial number of 78117241. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, July 20, 2018. This trademark is owned by Genzyme Transgenics Corporation. The GTC BIOTHERAPEUTICS trademark is filed in the Pharmaceutical Products, Treatment & Processing of Materials Services, and Computer & Software Services & Scientific Services categories with the following description:

[ Pharmaceutical preparations and vaccines for the treatment of myocardial infarction, cancer, multiple sclerosis, stroke, sepsis, heredity deficiency of the molecule leading to increased thrombolytic events, and heparin resistance in medical procedures; biologics; cells, cell lines and cell cultures for medical and clinical use in the production of proteins for therapeutic and diagnostic use; ] proteins [ and cloned DNA ] from [ humans, plants, ] animals [, bacteria and other micro-organisms ] for use as medical therapeutic reagents; transgenic and cloned animal products, namely, [ meat, tissue, cells or ] secretions for therapeutic and diagnostic use

[ Custom manufacture of transgenic animal products, namely, pharmaceuticals, biopharmaceuticals and proteins ]

[ Providing technical advice, research, testing and analysis in the field of pharmaceutical drug development; pharmaceutical drug development ]

General Information


Serial Number78117241
Word MarkGTC BIOTHERAPEUTICS
Filing DateMonday, March 25, 2002
Status710 - CANCELLED - SECTION 8
Status DateFriday, July 20, 2018
Registration Number3356991
Registration DateTuesday, December 18, 2007
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, October 28, 2003

Trademark Statements


Disclaimer with Predetermined Text"BIOTHERAPEUTICS"
Goods and Services[ Pharmaceutical preparations and vaccines for the treatment of myocardial infarction, cancer, multiple sclerosis, stroke, sepsis, heredity deficiency of the molecule leading to increased thrombolytic events, and heparin resistance in medical procedures; biologics; cells, cell lines and cell cultures for medical and clinical use in the production of proteins for therapeutic and diagnostic use; ] proteins [ and cloned DNA ] from [ humans, plants, ] animals [, bacteria and other micro-organisms ] for use as medical therapeutic reagents; transgenic and cloned animal products, namely, [ meat, tissue, cells or ] secretions for therapeutic and diagnostic use
Goods and Services[ Custom manufacture of transgenic animal products, namely, pharmaceuticals, biopharmaceuticals and proteins ]
Goods and Services[ Providing technical advice, research, testing and analysis in the field of pharmaceutical drug development; pharmaceutical drug development ]

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, July 20, 2018
Primary Code005
First Use Anywhere DateWednesday, February 19, 2003
First Use In Commerce DateWednesday, February 19, 2003

International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, July 20, 2018
Primary Code040
First Use Anywhere DateTuesday, September 30, 1997
First Use In Commerce DateTuesday, September 30, 1997

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, July 20, 2018
Primary Code042
First Use Anywhere DateSaturday, November 30, 1996
First Use In Commerce DateSaturday, November 30, 1996

Trademark Owner History


Party NameLABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES, S.A.
Party Type32 - New Owner After Registration
Legal Entity Type99 - Other
AddressLES ULIS 91940
FR

Party NameREVO BIOLOGICS, INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressFRAMINGHAM, MA 01702

Party NameGTC BIOTHERAPEUTICS, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressFRAMINGHAM, MA 01702

Party NameGTC BIOTHERAPEUTICS, INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressFRAMINGHAM, MA 01702

Party NameGenzyme Transgenics Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressFramingham, MA 01701

Party NameGenzyme Transgenics Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressFramingham, MA 01701

Trademark Events


Event DateEvent Description
Friday, July 20, 2018CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Sunday, December 18, 2016COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Thursday, July 10, 2014NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Thursday, July 10, 2014REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Monday, July 7, 2014CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, June 18, 2014TEAS SECTION 8 & 15 RECEIVED
Wednesday, April 9, 2014AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, March 5, 2014AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, December 18, 2007REGISTERED-PRINCIPAL REGISTER
Thursday, November 15, 2007LAW OFFICE REGISTRATION REVIEW COMPLETED
Thursday, November 15, 2007ASSIGNED TO LIE
Saturday, October 13, 2007ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, August 16, 2007STATEMENT OF USE PROCESSING COMPLETE
Monday, May 7, 2007USE AMENDMENT FILED
Thursday, August 16, 2007REVIEW OF CORRESPONDENCE COMPLETE
Tuesday, August 7, 2007FAX RECEIVED
Thursday, August 16, 2007EXTENSION 5 GRANTED
Monday, May 7, 2007EXTENSION 5 FILED
Monday, May 7, 2007PAPER RECEIVED
Monday, October 23, 2006EXTENSION 4 GRANTED
Monday, October 23, 2006EXTENSION 4 FILED
Monday, October 23, 2006TEAS EXTENSION RECEIVED
Thursday, April 13, 2006EXTENSION 3 GRANTED
Thursday, April 13, 2006EXTENSION 3 FILED
Thursday, April 13, 2006TEAS EXTENSION RECEIVED
Thursday, October 20, 2005EXTENSION 2 GRANTED
Thursday, October 20, 2005EXTENSION 2 FILED
Thursday, October 20, 2005TEAS EXTENSION RECEIVED
Friday, July 29, 2005TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, February 23, 2005EXTENSION 1 GRANTED
Monday, February 7, 2005EXTENSION 1 FILED
Monday, February 7, 2005TEAS EXTENSION RECEIVED
Tuesday, November 9, 2004NOA MAILED - SOU REQUIRED FROM APPLICANT
Monday, September 13, 2004CASE FILE IN TICRS
Wednesday, August 18, 2004EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Monday, December 15, 2003EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, October 28, 2003PUBLISHED FOR OPPOSITION
Wednesday, October 8, 2003NOTICE OF PUBLICATION
Friday, September 5, 2003APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, August 29, 2003EXAMINERS AMENDMENT MAILED
Monday, August 25, 2003FINAL REFUSAL MAILED
Thursday, July 31, 2003PREVIOUS ALLOWANCE COUNT WITHDRAWN
Saturday, June 28, 2003APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, May 27, 2003CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, May 27, 2003PAPER RECEIVED
Monday, April 14, 2003NON-FINAL ACTION MAILED
Friday, April 4, 2003PREVIOUS ALLOWANCE COUNT WITHDRAWN
Friday, February 14, 2003APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, February 14, 2003ASSIGNED TO EXAMINER
Wednesday, January 15, 2003CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, January 15, 2003PAPER RECEIVED
Monday, July 15, 2002NON-FINAL ACTION MAILED
Friday, July 12, 2002ASSIGNED TO EXAMINER